Vireo Growth (VREOF) EBT Margin (QoQ) (2020 - 2026)
Vireo Growth (VREOF) EBT Margin (QoQ) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.07 Bn | 39.42 Bn | 2.15 Bn |
| 3 | Zoetis | 31.53 Bn | 29.85 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.13 Bn | 19.47 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - |
| 10 | Vireo Growth | 491.44 Mn | 349.14 Mn | 95.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 757.00 |
| Dec 31, 2025 | 261.00 |
| Sep 30, 2025 | 684.00 |
| Jun 30, 2025 | -138.00 |
| Mar 31, 2025 | 2,580.00 |
| Dec 31, 2024 | -3,529.00 |
| Sep 30, 2024 | -919.00 |
| Jun 30, 2024 | 1,058.00 |
| Mar 31, 2024 | 339.00 |
| Dec 31, 2023 | -778.00 |
| Sep 30, 2023 | 2,131.00 |
| Jun 30, 2023 | 693.00 |
| Mar 31, 2023 | 319.00 |
| Dec 31, 2022 | 276.00 |
| Sep 30, 2022 | -1,692.00 |
| Jun 30, 2022 | 7,991.00 |
| Mar 31, 2022 | -1,802.00 |
| Dec 31, 2021 | -3,905.00 |
| Sep 30, 2021 | -432.00 |
| Jun 30, 2021 | -211.00 |